Mobiflox-OZ Tablet is a combination antibiotic product containing Ofloxacin (200mg) and Ornidazole (500mg). It is indicated for the treatment of bacterial infections such as urinary tract infections, respiratory tract infections, and soft tissue infections. Ofloxacin, a fluoroquinolone, exerts bactericidal activity against a wide range of gram-negative and gram-positive microorganisms, including Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. Ornidazole, a 5-nitroimidazole, demonstrates antimicrobial activity against anaerobic bacteria, including Bacteroides fragilis, Fusobacterium nucleatum, and Clostridium perfringens. The combination of Ofloxacin and Ornidazole in Mobiflox-OZ Tablet provides broad-spectrum coverage against both aerobic and anaerobic bacteria, making it an effective treatment option for patients presenting with symptoms of infection. The product is available in a tablet form, easy to administer, and has a well-established safety profile. It is essential to follow the recommended dosage and duration of treatment to ensure optimal therapeutic outcomes and minimize the risk of side effects.